首页> 外国专利> TREATMENT PLANNING BASED ON POLYPEPTIDE RADIOTOXICITY SERUM MARKERS

TREATMENT PLANNING BASED ON POLYPEPTIDE RADIOTOXICITY SERUM MARKERS

机译:基于多肽放射毒性血清标志物的治疗计划

摘要

A method includes at least one of creating or adapting a treatment plan for a patient based on a set of serum polypeptides of the patient that are indicative of a radiotoxicity of the patient at least one of before or after at least one of a plurality of radiotherapy treatments of the treatment plan, wherein the radiotoxicity is induced by radiation exposure from the radiotherapy treatment. A system includes a treatment planning device (108) that facilitates at least one of creating or adapting a treatment plan for a patient based on amounts or concentrations of a set of serum polypeptides of the patient that indicate a high risk of or an early radiotoxicity of the patient to radiation from radiotherapy.
机译:一种方法包括以下至少一项:基于患者的一组血清多肽为患者创建或调整患者的治疗计划,所述血清多肽指示在多种放射疗法中至少一项之前或之后的至少一项对患者的放射毒性治疗计划的治疗,其中放射毒性是由放射疗法的放射线照射引起的。一种系统,包括治疗计划设备( 108 ),该设备有助于根据患者血清中指示高血脂水平的一组血清多肽的量或浓度为患者创建或调整治疗计划中的至少一项患者对放射治疗产生的辐射风险或早期放射毒性。

著录项

  • 公开/公告号US2014113388A1

    专利类型

  • 公开/公告日2014-04-24

    原文格式PDF

  • 申请/专利权人 KATRIN BITTER;CAROLINA RIBBING;

    申请/专利号US201214125991

  • 发明设计人 KATRIN BITTER;CAROLINA RIBBING;

    申请日2012-06-29

  • 分类号A61N5/10;

  • 国家 US

  • 入库时间 2022-08-21 16:06:52

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号